Mariana Alves Pereira Zóia Selected Research

bothropstoxin II

1/2022	A New Approach to Inhibiting Triple-Negative Breast Cancer: In Vitro, Ex Vivo and In Vivo Antiangiogenic Effect of BthTx-II, a PLA2-Asp-49 from Bothrops jararacussu Venom.
8/2019	Antitumor and antimetastatic effects of PLA2-BthTX-II from Bothrops jararacussu venom on human breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mariana Alves Pereira Zóia Research Topics

Disease

4	Triple Negative Breast Neoplasms 01/2022 - 03/2019
2	Neoplasms (Cancer) 01/2022 - 04/2019
2	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Sarcoma 180 04/2019
1	Sarcoma (Soft Tissue Sarcoma) 04/2019

Drug/Important Bio-Agent (IBA)

2	bothropstoxin IIIBA 01/2022 - 08/2019
2	VenomsIBA 01/2022 - 08/2019
2	Annexin A1IBA 01/2022 - 03/2019
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	matrigelIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Ketoconazole (Nizoral)FDA LinkGeneric 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	CopperIBA 04/2019
1	MetalsIBA 04/2019
1	1,10-phenanthrolineIBA 04/2019
1	Biological ProductsIBA 04/2019
1	Cathepsin DIBA 03/2019

Therapy/Procedure

1	Therapeutics 01/2022